{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:45:09Z","timestamp":1793051109252,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515110630"],"award-info":[{"award-number":["2020A1515110630"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["14103121"],"award-info":[{"award-number":["14103121"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["14109721"],"award-info":[{"award-number":["14109721"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["4108322"],"award-info":[{"award-number":["4108322"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["14103420"],"award-info":[{"award-number":["14103420"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800802"],"award-info":[{"award-number":["2018YFA0800802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010909","name":"Excellent Young Scientists Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"Department of Science and Technology of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Committee","doi-asserted-by":"publisher","award":["JCYJ20160229210357960"],"award-info":[{"award-number":["JCYJ20160229210357960"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304378"],"award-info":[{"award-number":["82304378"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["T12-201-20R"],"award-info":[{"award-number":["T12-201-20R"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["4054714"],"award-info":[{"award-number":["4054714"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001747","name":"Hong Kong Baptist University","doi-asserted-by":"publisher","award":["RC-IRCs\/17-18\/02"],"award-info":[{"award-number":["RC-IRCs\/17-18\/02"]}],"id":[{"id":"10.13039\/501100001747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["2022WK2010"],"award-info":[{"award-number":["2022WK2010"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.canlet.2024.217102","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T16:39:52Z","timestamp":1720024792000},"page":"217102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy"],"prefix":"10.1016","volume":"598","author":[{"given":"Yuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-5777","authenticated-orcid":false,"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-7695","authenticated-orcid":false,"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.217102_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215761","article-title":"The mevalonate pathway in breast cancer biology","volume":"542","author":"G\u00f6bel","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.canlet.2024.217102_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.836417","article-title":"Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence","volume":"9","author":"Almansour","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.canlet.2024.217102_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032969","article-title":"Triple-negative breast cancer and predictive markers of response to neoadjuvant chemotherapy: a systematic review","volume":"24","author":"van den Ende","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2024.217102_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215849","article-title":"A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice","volume":"548","author":"Bahreyni","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2174\/1574892816666211130170149","article-title":"Prognostic and therapeutic values of autophagy-related genes in triple-negative breast cancer","volume":"17","author":"Liu","year":"2022","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.canlet.2024.217102_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215717","article-title":"The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events","volume":"540","author":"Timilsina","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216345","article-title":"Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers","volume":"571","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.217102_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202206169","article-title":"Enhancing the release efficiency of a molecular chemotherapeutic prodrug by photodynamic therapy","volume":"61","author":"Yuan","year":"2022","journal-title":"Angew. Chem."},{"key":"10.1016\/j.canlet.2024.217102_bib11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chembiol.2021.08.016","article-title":"Hypoxia-activated KDAC inhibitor: taking a breath from untargeted therapy","volume":"28","author":"Staudt","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2024.217102_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7150\/thno.17099","article-title":"Smart Cu(II)-aptamer complexes based gold nanoplatform for tumor micro-environment triggered programmable intracellular prodrug release, photodynamic treatment and aggregation induced photothermal therapy of hepatocellular carcinoma","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.217102_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00280-015-2920-7","article-title":"Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs","volume":"77","author":"Phillips","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217102_bib14","article-title":"Selectively potentiating hypoxia levels by combretastatin A4 nanomedicine: toward highly enhanced hypoxia-activated prodrug tirapazamine therapy for metastatic tumors","volume":"31","author":"Yang","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2024.217102_bib15","article-title":"Innovative strategies for photodynamic therapy against hypoxic tumor","volume":"18","author":"Li","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.canlet.2024.217102_bib16","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1021\/acs.nanolett.0c00502","article-title":"Upconverting nanocarriers enable triggered microtubule inhibition and concurrent ferroptosis induction for selective treatment of triple-negative breast cancer","volume":"20","author":"Zhu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114138","article-title":"Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect","volume":"183","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2024.217102_bib18","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1039\/C9BM00002J","article-title":"An eximious and affordable GSH stimulus-responsive poly(alpha-lipoic acid) nanocarrier bonding combretastatin A4 for tumor therapy","volume":"7","author":"Liu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.canlet.2024.217102_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2020.11.045","article-title":"Hypoxia-mediated drug resistance in breast cancers","volume":"502","author":"McAleese","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199105","article-title":"Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens","volume":"13","author":"Srivastava","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2024.217102_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100849","article-title":"New insights into antiangiogenic therapy resistance in cancer: mechanisms and therapeutic aspects","volume":"64","author":"Huang","year":"2022","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.canlet.2024.217102_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100884","article-title":"Targeting feedback activation of signaling transduction pathways to overcome drug resistance in cancer","volume":"65","author":"Wang","year":"2022","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.canlet.2024.217102_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-020-01613-y","article-title":"HIF-1alpha-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4","volume":"39","author":"Yu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. : CRN"},{"key":"10.1016\/j.canlet.2024.217102_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215763","article-title":"LncRNAs driving feedback loops to boost drug resistance: sinuous pathways in cancer","volume":"543","author":"S\u00e1nchez-Mar\u00edn","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib25","article-title":"Chemically modified aptamers for improving binding affinity to the target proteins via enhanced non-covalent bonding","volume":"11","author":"Chen","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.217102_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/acsanm.3c05036","article-title":"Aptamer-modified zinc ferrite nanoparticles for autophagy-mediated chemotherapy and MR imaging of ovarian cancer","volume":"7","author":"Zhu","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.canlet.2024.217102_bib27","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","article-title":"Recent progress of aptamer\u2012drug conjugates in cancer therapy","volume":"13","author":"He","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2024.217102_bib28","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.chembiol.2023.10.010","article-title":"Anti-tumor effect of PD-L1-targeting antagonistic aptamer-ASO delivery system with dual inhibitory function in immunotherapy","volume":"30","author":"Luo","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2024.217102_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216461","article-title":"Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts","volume":"579","author":"Niu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib30","article-title":"Overcoming the blood-brain barrier for gene therapy via systemic administration of GSH-responsive silica nanocapsules","volume":"35","author":"Wang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.canlet.2024.217102_bib31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biomaterials.2018.12.033","article-title":"Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo","volume":"197","author":"Ma","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2024.217102_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216157","article-title":"Cope with copper: from copper linked mechanisms to copper-based clinical cancer therapies","volume":"561","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.101018","article-title":"Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance","volume":"72","author":"Wang","year":"2024","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.canlet.2024.217102_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216348","article-title":"Copper in hepatocellular carcinoma\uff1a A double-edged sword with therapeutic potentials","volume":"571","author":"Wu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2024.217102_bib35","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1021\/jacs.3c00841","article-title":"Aptamer-based targeted delivery of functional nucleic acids","volume":"145","author":"Xie","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2024.217102_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100851","article-title":"Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics","volume":"32","author":"Gong","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.canlet.2024.217102_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7150\/thno.21342","article-title":"A novel DNA aptamer for dual targeting of polymorphonuclear myeloid-derived suppressor cells and tumor cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2024.217102_bib38","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/en.2003-1639","article-title":"Hypoxia-inducible factor-1 transactivates transforming growth factor-beta3 in trophoblast","volume":"145","author":"Nishi","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2024.217102_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202000074","article-title":"Modularly engineered solid\u2010phase synthesis of aptamer\u2010functionalized small molecule drugs for targeted cancer therapy","author":"Wang","year":"2020","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.canlet.2024.217102_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biomaterials.2018.06.012","article-title":"Annealing novel nucleobase-lipids with oligonucleotides or plasmid DNA based on H-bonding or pi-pi interaction: assemblies and transfections","volume":"178","author":"Ma","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2024.217102_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-019-1112-1","article-title":"The PI3K subunits, P110alpha and P110beta are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.217102_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biomaterials.2017.11.001","article-title":"Versatile hyaluronic acid modified AQ4N-Cu(II)-gossypol infinite coordination polymer nanoparticles: multiple tumor targeting, highly efficient synergistic chemotherapy, and real-time self-monitoring","volume":"154","author":"Shen","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2024.217102_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/1574892817666220713150521","article-title":"Application of nano drug delivery system (NDDS) in cancer therapy: a perspective","volume":"18","author":"Liu","year":"2022","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.canlet.2024.217102_bib44","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1038\/s41598-022-07533-5","article-title":"Effect of morpholine and charge distribution of cyanine dyes on cell internalization and cytotoxicity","volume":"12","author":"Wangngae","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2024.217102_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100889","article-title":"Precision medicine: ray of hope in overcoming cancer multidrug resistance","volume":"65","author":"Musyuni","year":"2022","journal-title":"Drug Resist. Updates : Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.canlet.2024.217102_bib46","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.apsb.2022.10.002","article-title":"Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.canlet.2024.217102_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115518","article-title":"DHMMF, a natural flavonoid from Resina Draconis, inhibits hepatocellular carcinoma progression via inducing apoptosis and G2\/M phase arrest mediated by DNA damage-driven upregulation of p21","volume":"211","author":"Tian","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2024.217102_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13205-023-03461-x","article-title":"Capparis zeylanica L. root extract promotes apoptosis and cell cycle arrest, inhibits epithelial-to-mesenchymal transition and triggers E-cadherin expression in breast cancer cell lines","volume":"13","author":"Venkataswamy","year":"2023","journal-title":"3 Biotech"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400497X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352400497X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:06:10Z","timestamp":1777550770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352400497X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":48,"alternative-id":["S030438352400497X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217102","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217102"}}